To avoid information blocking pitfalls, build your health data strategy around prompt, standards-based access to electronic health information and documented exception decisions. Compliance works best when sharing is the default and every restriction has a defined legal and operational basis.
Your organization may be investing in interoperability, analytics, and Artificial Intelligence (AI) readiness, yet routine access decisions can still create regulatory exposure. Delayed responses, restricted interfaces, weak export functions, and inconsistent policies often reflect data governance problems rather than isolated compliance errors. A practical strategy aligns technology, contracts, access workflows, and documentation with the information blocking rules.
What Is Information Blocking And Why Does It Threaten Your Health Data Strategy?
Information blocking is a practice by a regulated actor that is likely to interfere with, prevent, or materially discourage the access, exchange, or use of electronic health information. A practice generally avoids that classification when it is required by law or meets the conditions of an information blocking exception. The rule comes from the 21st Century Cures Act and regulations administered by the Office of the National Coordinator for Health Information Technology (ONC). It reaches operational decisions across your technology, compliance, records, security, and contracting teams.
The word “blocking” can suggest deliberate refusal, but risk can also emerge from routine procedures that make access difficult. Manual approvals, unclear request channels, restrictive vendor terms, and limited export capabilities can slow or discourage legitimate data use. Your organization should review the practical effect of a policy, not just the reason the policy was adopted. A well-intended procedure can still interfere with access when it adds unnecessary cost, delay, or technical barriers.
Treating information blocking as a narrow legal issue creates gaps between written policy and daily operations. Your health data strategy should connect compliance requirements to system design, release-of-information workflows, application programming interfaces (APIs), and data governance. That connection also supports broader goals related to patient access, interoperability, and reliable analytics. Data liquidity becomes an operational requirement rather than a future technology project.
Who Must Comply With Information Blocking Rules?
The information blocking rules apply to three actor categories: healthcare providers, health information technology developers of certified health information technology, and health information networks or health information exchanges. Your first task is to determine which category applies to each legal entity and business function. A health system may work with several outside organizations that have their own responsibilities under the rule. Actor status shapes the enforcement route and the operational questions your compliance program must address.
Healthcare providers need to examine how clinicians, records teams, privacy staff, and technology departments process requests for electronic health information. Developers should review product functions, licensing terms, interfaces, exports, and customer restrictions. Networks and exchanges need to assess participation agreements, connection requirements, and exchange practices. Vendor responsibility does not remove your organization’s duty to review the restrictions built into its systems and contracts.
The rules are not limited to requests submitted through a patient portal. They address access, exchange, and use of electronic health information across permitted workflows. Internal restrictions also deserve review when they interfere with authorized data use or make information unavailable to the people and systems that need it. Mapping actors, systems, request types, and decision owners helps you find gaps before a complaint or enforcement review exposes them.
What Counts As Electronic Health Information?
Electronic health information (EHI) is a legal term tied to electronic protected health information within the designated record set defined under the Health Insurance Portability and Accountability Act (HIPAA). Its scope extends beyond the United States Core Data for Interoperability (USCDI) data elements that shaped the earlier phase of the rule. Your data inventory must account for the broader designated record set rather than a limited collection of clinical fields. Relying only on certified module exports or portal-visible information may leave relevant data outside your access process.
A designated record set can include records used to make decisions about an individual, not just notes and laboratory results displayed in an electronic health record (EHR). Billing information, care management records, and other electronically maintained information may require review based on how your organization uses them. Data location does not determine whether information falls within scope. Information stored in an archive, departmental application, or contracted platform can still matter.
Your governance team should maintain an inventory that identifies each system, its data owner, its export capabilities, and whether it contains information used to make decisions about individuals. That inventory should include legacy applications, acquired practice systems, data warehouses, and third-party services. You can then compare your legal access obligations with the data your current tools can retrieve. This exercise often reveals that a technical export is incomplete even when the primary EHR is functioning as designed.
How Do The Eight Information Blocking Exceptions Work?
The regulation contains eight exceptions divided into two groups: exceptions involving practices that do not fulfill a request and exceptions covering procedures used to fulfill a request. Meeting an exception depends on satisfying its applicable conditions, not merely using its name in a policy or denial notice. Your organization should treat each exception as a decision path with defined facts, approvals, and records. A general statement about privacy, security, cost, or patient safety is not enough.
The preventing harm exception is a common area of concern because it requires an individualized determination under the applicable conditions. Blanket rules that automatically withhold a category of information generally do not satisfy that standard. Your workflow should record the specific risk, the decision maker, the information affected, and why the chosen restriction is no broader than needed. Repeating the same language for every case can weaken the credibility of the record.
The fee exception also requires careful review. Charges for access, exchange, or use of EHI must fit the exception and rely on allowable cost categories when the exception applies. A vendor invoice or established rate does not automatically make a fee compliant. Your legal, finance, and technology teams should review what a charge covers, how it was calculated, who must pay it, and whether it could discourage permitted access.
Which Information Blocking Pitfalls Create The Most Risk?
Common information blocking pitfalls arise when operational restrictions become the default response to data requests. Your team may delay access because ownership is unclear, an approval queue has no deadline, or a legacy system requires manual work. Technical teams may limit access to a proprietary portal when a usable export or standards-based connection is needed. These practices deserve review based on their effect on access, exchange, or use.
Non-standard interfaces and weak export functions can create another problem. An API may exist, yet authentication barriers, limited data fields, poor documentation, or contract restrictions can make it impractical to use. A patient-facing download may also fall short when it excludes EHI maintained elsewhere in the organization. Your testing should evaluate whether a person or authorized recipient can obtain usable information, not simply whether a button or interface is available.
Inconsistent policies across hospitals, clinics, and departments add avoidable risk. One location may release data promptly, another may require added approval, and a third may refuse the same request based on an unwritten practice. Contract terms can compound the problem by restricting migration, imposing questionable access fees, or limiting connections to other platforms. Central governance should identify these variations and replace them with documented rules that permit limited local adjustments.
How Should You Build Compliance Into Your Health Data Strategy?
Start with a default-sharing principle: fulfill permitted EHI requests unless a law or properly applied exception supports a restriction. That principle should appear in policy, system requirements, vendor selection, and staff training. It gives decision makers a consistent starting point without removing necessary privacy or security review. It also reduces the tendency to treat every unfamiliar request as a reason to withhold data.
Your technical plan should support standards-based exchange, usable exports, and patient access APIs. Health Level Seven Fast Healthcare Interoperability Resources (HL7 FHIR) can support structured exchange when the relevant systems and use cases permit it. Technical compliance still requires more than installing an interface. You need to test data completeness, response performance, authentication, documentation, and the restrictions created by contracts or licensing terms.
Governance should connect legal requirements to named operational owners. Assign responsibility for request intake, identity verification, exception review, technical delivery, fee approval, escalation, and record retention. Measure request age, denial reasons, exception use, incomplete exports, complaints, and recurring system barriers. Regular review helps you distinguish an isolated processing error from a policy or technology problem that requires correction.
How Should You Document Exceptions And Prepare For Enforcement?
Your documentation should show the facts considered, the applicable exception, the decision maker, and the reason the restriction met every required condition. Record the scope and duration of the restriction, along with any alternative access method offered. Generic templates can help organize the review, but they should not replace an individualized analysis. The record must explain what happened in that request rather than repeat broad policy language.
Enforcement differs by actor type. The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) may impose civil monetary penalties of up to $1 million per violation on certified health technology developers, health information networks, and health information exchanges. Healthcare provider enforcement follows separate disincentive mechanisms administered through the Centers for Medicare & Medicaid Services (CMS) and other applicable federal processes. Your organization should confirm its actor category instead of assuming one enforcement model applies to every entity.
Prepare for review by preserving request records, correspondence, access logs, fee calculations, exception analyses, and evidence of technical delivery. Audit samples should cover approved requests, denied requests, delayed requests, and cases involving third-party applications. Review vendor agreements for data ownership, migration support, interface access, export charges, and termination assistance. A defensible program shows that your written rules, system settings, contracts, and actual decisions support permitted data access.
What Are The Most Common Information Blocking Pitfalls?
- Restricting access through non-standard interfaces
- Creating unnecessary response delays
- Charging fees outside allowable conditions
- Using blanket harm determinations
- Limiting usable data exports
Make Data Sharing An Operational Standard
Avoiding information blocking pitfalls requires more than adding regulatory language to an existing privacy policy. You need a reliable data inventory, usable exchange methods, defined request owners, reviewed vendor terms, and records that support every exception decision. Build sharing into system design and daily workflows, then measure where delays, fees, incomplete exports, or inconsistent decisions still occur. Privacy and security controls remain part of that process, but they should be applied through documented legal requirements rather than automatic restrictions. When your technology and governance support appropriate access by default, compliance becomes part of normal data operations instead of a separate response to complaints.
Resources
- Office of the National Coordinator for Health Information Technology: Information Blocking
- Office of the National Coordinator for Health Information Technology: Cures Act Final Rule
- Electronic Code of Federal Regulations: Title 45, Part 171
- Department of Health and Human Services Office of Inspector General: Information Blocking Enforcement
- Centers for Medicare & Medicaid Services: Interoperability and Patient Access
- Federal Register: Interoperability, Information Blocking, and Health Technology Certification Final Rule.
Maurizio Chiriva Internati (DBSc, PhDs) is a cancer immunologist and biotech entrepreneur with 20+ years in immuno-oncology. Co-founder and former CEO of Kiromic BioPharma (NASDAQ: KRBP), he has led AI-driven target discovery and translational programs, and has served on faculty at MD Anderson and Texas Tech.
